Evidence map›Paper›PMID 35550376›Full record

ArticleThe Journal of clinical investigation2022

Factors influencing maternal microchimerism throughout infancy and its impact on infant T cell immunity.

Christina Balle, Blair Armistead, Agano Kiravu, Xiaochang Song, Anna-Ursula Happel, Angela A Hoffmann, Sami B Kanaan, J Lee Nelson, Clive M Gray, Heather B Jaspan and 1 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Identifying Key Questions and Challenges in Microchimerism Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Christina BalleDivision of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Blair ArmisteadSeattle Children's Research Institute, Seattle, Washington, USA.
Agano KiravuDivision of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Xiaochang SongSeattle Children's Research Institute, Seattle, Washington, USA.
Anna-Ursula HappelDivision of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Angela A HoffmannDivision of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Sami B KanaanClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
J Lee NelsonClinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Clive M GrayDivision of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Heather B JaspanDivision of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Whitney E HarringtonSeattle Children's Research Institute, Seattle, Washington, USA.
University of Cape Town · ZAFred Hutch Cancer Center · USUniversity of Washington · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Mucosal microbiome and vaccine responses in HIV-exposed African infantsR01AI120714 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI JASPAN, HEATHER BERYL · 2016 to 2020
$2.2M
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infantsU01AI131302 · NIAID · STANFORD UNIVERSITY · PI BLISH, CATHERINE A, GRAY, CLIVE MAURICE · 2017 to 2021
$2.1M
The Effect of Maternal Cells on Infant ImmunityK08AI135072 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI HARRINGTON, WHITNEY ELIZABETH · 2018 to 2022
$854k
The Maternal Immune Legacy of In Utero HIV ExposureR21AI157821 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI HARRINGTON, WHITNEY ELIZABETH · 2021 to 2022
$474k
Mechanisms by which trophoblasts recruit T cells to the placental villi during maternal HIV and CMV co-infectionR21HD103498 · NICHD · MAYO CLINIC ROCHESTER · PI CHAKRABORTY, RANA, GRAY, CLIVE MAURICE · 2020 to 2021
$390k
NIAID NIH HHS K08 AI135072NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI120714NIAID NIH HHS R21 AI157821NIAID NIH HHS T32 AI007509NIAID NIH HHS U01 AI131302NICHD NIH HHS R21 HD103498Wellcome Trust
6 · The paper itself

Abstract

Determinants of the acquisition and maintenance of maternal microchimerism (MMc) during infancy and the impact of MMc on infant immune responses are unknown. We examined factors that influence MMc detection and level across infancy and the effect of MMc on T cell responses to bacillus Calmette-Guérin (BCG) vaccination in a cohort of HIV-exposed, uninfected and HIV-unexposed infants in South Africa. MMc was measured in whole blood from 58 infants using a panel of quantitative PCR assays at day 1, and 7, 15, and 36 weeks of life. Infants received BCG at birth, and selected whole blood samples from infancy were stimulated in vitro with BCG and assessed for polyfunctional CD4+ T cell responses. MMc was present in most infants across infancy, with levels ranging from 0 to 1,193/100,000 genomic equivalents and was positively impacted by absence of maternal HIV, maternal and infant HLA compatibility, infant female sex, and exclusive breastfeeding. Initiation of maternal antiretroviral therapy prior to pregnancy partially restored MMc level in HIV-exposed, uninfected infants. Birth MMc was associated with an improved polyfunctional CD4+ T cell response to BCG. These data emphasize that both maternal and infant factors influence the level of MMc, which may subsequently affect infant T cell responses.

Indexed as

HIV InfectionsT-LymphocytesBCG VaccineChimerismFemaleHumansInfantInfant, NewbornPregnancyVaccinationBCG VaccineAIDS/HIVBacterial vaccinesImmunologyObstetrics/gynecologyT cells

Identifiers

PMID35550376
PMCPMC9246390
OpenAlexW4280602643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.